The epidemiology and control of Acinetobacter baumannii in health care facilities.

@article{Fournier2006TheEA,
  title={The epidemiology and control of Acinetobacter baumannii in health care facilities.},
  author={Pierre-Edouard Fournier and Herv{\'e} M. Richet},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2006},
  volume={42 5},
  pages={
          692-9
        }
}
  • P. Fournier, H. Richet
  • Published 1 March 2006
  • Medicine, Biology
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Acinetobacter baumannii is a ubiquitous pathogen capable of causing both community and health care-associated infections (HAIs), although HAIs are the most common form. This organism has emerged recently as a major cause of HAI because of the extent of its antimicrobial resistance and its propensity to cause large, often multifacility, nosocomial outbreaks. The occurrence of outbreak is facilitated by both tolerance to desiccation and multidrug resistance, contributing to the maintenance of… 
NOSOCOMIAL INFECTIONS CAUSED BY ACINETOBACTER BAUMANII THE DIFFICULTY OF THE THERAPY CONCERNING MULTIDRUG RESISTANCE
TLDR
The clinical aspects associated to Acinetobacter baumanii nosocomial infections in the County Emergency Clinical Hospital in Sibiu are described and also their present susceptibility to antibiotherapy, evolution and prognosis are described.
Epidemiological Monitoring of Nosocomial Infections Caused by Acinetobacter Baumannii
TLDR
The increasing incidence of multi- and extensively drug-resistant Acinetobacter spp.
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
TLDR
A. baumannii has developed a broad spectrum of antimicrobial resistance, associated with a higher mortality rate among infected patients compared with other non-baumannii species, and further research into their clinical use is required.
Multidrug-Resistant Acinetobacter baumannii: A Growing Worldwide Problem
TLDR
A clinical vignette describes the first case of multidrug-resistant A. baumannii complex (sensitive only to colisitin and high-dose ampicillin-sulbactam) isolated at the authors' institution.
Community-Acquired Acinetobacter baumannii Infections in NorthernCalifornia
TLDR
Community-acquired A. baumannii infections caused a variety of serious clinical syndromes; most commonly wound infections, but also urinary tract infections, pneumonia and septic shock.
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.
TLDR
A deep understanding of the resistance mechanisms used by MDRAB can shed light on two possible strategies to combat the dissemination of antimicrobial resistance and to develop and evaluate the efficacy of new antibiotics and to understand the role of other potential alternatives in the treatment ofMDRAB infections.
Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii
TLDR
After controlling for patient location in an intensive care unit, transfer from another facility, and length of hospital stay before culture, there was no longer an independent association between IRAB infection or colonization and higher cost after culture, and strategies to optimize therapy are needed.
Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
TLDR
The enzymes within the OXA, NDM, VIM, IMP, and KPC groups of carbapenemases and the coding genes found in A. baumannii clinical isolates are described.
Study of Antibiotic Resistance of Acinetobacter baumannii in Intensive Care Units (I.C.Us) and Burn Patients
The genus Acinetobacter is a major cause of nosocomial infections; it is increasingly being associated with various epidemics and has become a widespread concern in a variety of hospitals worldwide.
Community-Acquired Acinetobacter baumannii Infections in Northern
TLDR
Community-acquired A. baumannii infections caused a variety of serious clinical syndromes; most commonly wound infections, but also urinary tract infections, pneumonia and septic shock.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 83 REFERENCES
Nosocomial Acinetobacter baumannii Infections: Microbiological and Clinical Epidemiology
TLDR
The combined use of molecular typing methods and casecontrol studies was crucial for elucidating the epidemiology of nosocomial A. baumannii infections and for identifying the role played by the use of antimicrobial agents in the persistence of multidrug-resistant clones.
Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii.
TLDR
Antibiotics, Foley catheters, and tracheostomy/ventilator usage were strongly associated with AB isolation, indicating colonization is a marker of severe illness but is not necessarily causal.
Clinical Features and Epidemiology of Acinetobacter baumannii Colonization and Infection in Spanish Hospitals
TLDR
A. baumannii was present in most participating Spanish hospitals (particularly in ICUs) with different rates among them, and mainly affected predisposed patients; half of them were only colonized.
Acinetobacter Outbreaks, 1977–2000
Abstract This review of Acinetobacter outbreaks summarizes factors related to the presence and recognition of organism transmission and describes the implementation of control and prevention measures
Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
  • A. Levin, A. Barone, +5 authors S. Costa
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1999
TLDR
Colistin may be a good therapeutic option for the treatment of severe infections caused by multidrug-resistant P. aeruginosa and A. baumannii.
Treatment of Acinetobacter spp. infections
  • A. Levin
  • Biology, Medicine
    Expert opinion on pharmacotherapy
  • 2003
Acinetobacter spp. are predominantly nosocomial pathogens of growing importance. One of their important features is antimicrobial resistance that includes β-lactams, aminoglycosides and quinolones.
Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting.
TLDR
Plasmid DNA analysis proved to be useful in epidemiological typing of A baumannii strains and may serve as a complementary typing system to traditional epidemiological methods.
Acinetobacter bacteremia in Hong Kong: prospective study and review.
TLDR
Genotyping by arbitrarily primed polymerase chain reaction analysis and the temporal sequence of isolation were more useful than phenotypes by antimicrobial susceptibility in the determination of the source of bacteremia, and the intravascular catheter was the leading infection source.
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Acinetobacter baumannii is a species of nonfermentative gram-negative bacteria commonly found in water and soil. This organism was susceptible to most antibiotics in the 1970s. It has now become a
...
1
2
3
4
5
...